Navigation Links
ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
Date:3/31/2008

TUCSON, Ariz., March 31 /PRNewswire/ -- ImaRx Therapeutics, Inc., a biopharmaceutical company developing and commercializing therapies for vascular disorders, today provided a corporate update along with fourth quarter and full year 2007 financial results.

2007 Year in Review:

-- Initiated TUCSON Phase I/II clinical study

-- Received FDA approval to market urokinase under new trade name

Kinlytic(TM)

-- Signed strategic licensing agreement with Bracco International

-- Completed Initial Public Offering

-- Awarded Phase I STTR grant from the National Institutes of Health

-- Signed research collaboration with Royal Philips Electronics

-- Extended expiration dating of urokinase product inventory

Key Corporate Highlights:

PhaseI/II TUCSON Clinical Trial and SonoLysis Program Update

In January of 2007, the Company initiated its TUCSON trial, a Phase I/II clinical study designed to assess the safety of the Company's proprietary MRX- 801 microbubbles in combination with ultrasound and tPA in ischemic stroke patients. The TUCSON trial was designed with four 18-patient cohorts to evaluate increasing doses of MRX-801. In the second dose cohort, the Company observed a greater number of reported symptomatic intracranial hemorrhages in subjects receiving treatment relative to controls and after consultation with the Data and Safety Monitoring Board elected to stop enrollment of the study.

Bradford A. Zakes, President and CEO stated, "Although we would have preferred to obtain more efficacy and safety data at higher doses of microbubbles, we were encouraged by the data from the first cohort of patients. One vial of MRX-801 in combination with ultrasound and tPA did not result in any reported cases of intracranial hemorrhage in the treatment group, suggesting a safe dose for further clinical studies. Furthermore, an analysis of activity from the first cohort indicated a trend
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
2. ImaRx to Report Corporate Updates and 4Q07 Financial Results
3. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
6. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
7. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
8. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
9. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
10. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
11. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
... computing performance were developed at the comp...ents at the University of Wisconsin-Madison. , ,In...rmance, distributed database architectures, grid a... touted by Professor Guri Sohi, department chair, ...isons monthly meeting. , ,Pentium-class microproc...
...unced on Tuesday that they have continued their tr... introduction of their newest model in the Illumin...e new lights which offer 50 percent more light at ...fixture, able to reach heights between 14 and 100 ...ercial and industrial facilities, such as warehous...
...d company that makes industrial control systems, h...ware , a privately owned Massachusetts company. , ...ckwell,s call-center solution, known as FirstPoint...ale will allow Rockwell to focus on its industrial...ny,s chief executive, said in a statement. , ,Con...
...tion Networks Corp. has released a new version of...nd text messages to be sent over an intranet to co...new version, InformaCast 3.1 , adds features such...-IP phones, and add predefined text messages to vo...Manager, Berbee said. , ,It also allows messages t...
Other Biology Technology:UW computer scientists tout achievements and explain industry shortcomings 2UW computer scientists tout achievements and explain industry shortcomings 3
(Date:10/7/2008)...e might be the secret weapon for winning the war a...son University have designed and tested a nutritio...each students how to evaluate their dietary intake...Department of Agriculture,s MyPyramid.gov for Ki...at allows kids to win by fueling their rocket with...
(Date:10/6/2008)... Office Replaces Passwords with Fingerprint ...HANHASSEN, Minn. and WALL, N.J., Oct. 6 /PRNewswir...lletin Board: BKYI), a leader in,finger-based biom...lutions,and its partner Sig-Tec, a leader in iden...ounced today the successful deployment of a,finger...
(Date:10/6/2008)... drug can prevent -- and even reverse -- potential... progeria, a rare genetic disorder that causes the...onal Institutes of Health (NIH) researchers report... early online edition of the Proceedings of the N...s S. Collins, M.D., Ph.D., of the National Human G...
(Date:10/6/2008)..., A study by biologists at Washington University i...ulation is in an area, the less chance humans have...,s hear it for the birds. , "The bottom line is t...yard, you have much lower risk of contracting West... in biology in Arts & Sciences at Washington Unive...
Breaking Biology News(10 mins):'Color My Pyramid' nutrition education program battles obesity in DC schools 2Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency 2Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency 3Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency 4Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder 2Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder 3Study: Bird diversity lessens human exposure to West Nile Virus 2Carbon dioxide scrubber captures greenhouse gases 5117 1Carbon dioxide scrubber captures greenhouse gases 5117 2Carbon dioxide scrubber captures greenhouse gases 5117 3Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 1Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 2Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 3Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 4Commercial aquatic plants offer cost effective method for treating wastewater 5113 1Commercial aquatic plants offer cost effective method for treating wastewater 5113 2Experts to discuss global water crisis 5109 1Experts to discuss global water crisis 5109 2
...k to the amazing repertoire of carbon nanotubes --...cells. , Nanotubes, tiny hollow carbon filaments a...ir, are already famed as one of the most versatile...ong as steel and one-sixth as dense, able to condu... for silicon in semiconductor chips, carbon nanotu...
...an that 2006 is shaping up as the worst year for C...cording to Art Shapiro, professor of evolution and...ast spring, when millions of painted lady butterfl... species have seen steep declines in recent years ... "It has been the worst spring for butterflies of ...
...ed in Chinese medicine to treat the symptoms of ty...reverses some of the pancreatic dysfunctions that ...ne 7, 2006, Cell Metabolism. The chemical therefor...tes therapies, they said. , Such a drug could offe...available therapy for diabetes actually targets th...
...lar disease and cancer in Asia where people smoke ...ption of tea, particularly green tea, according to...dicine researcher. , "We do not yet have a full ex... the very low incidence of both heart disease and ...tes is greater than in most other countries," said...
Other Biology News:Nanotubes used for first time to send signals to nerve cells 2Where have all the butterflies gone? 2Gardenia fruit compound starting point for diabetes therapy 2Green tea and the 'Asian Paradox' 2
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface.
Antibeta-lactoglobulin monoclonal antibody(CD-2)
MAb to Vasopressin Preservative: NaN3
...α, clone 8G8/5 GenBank Accession Number : N...lpha/gamma fusion protein corresponding to residue...0 of human AP-2γ Formulation: 0.1M Tris-glyc... the addition of glycerol to 30% Quality Assurance...
Biology Products: